Maxcyte (MXCT) Goodwill & Intangibles (2025 - 2026)
Maxcyte's (MXCT) quarterly Goodwill & Intangibles came in at $783000.0 in Q1 2026, down 82.86% year-on-year from $4.6 million in Q1 2025, and up 20.46% on a QoQ basis from $650000.0 in Q4 2025.
Maxcyte (MXCT) Goodwill & Intangibles (2025 - 2026) Analysis & Trends
Maxcyte (MXCT) has 2 years of Goodwill & Intangibles data on file, last reported at $783000.0 in Q1 2026.
- On a quarterly basis, Goodwill & Intangibles fell 82.86% year-over-year to $783000.0 in Q1 2026; TTM through Mar 2026 was $783000.0, a 82.86% decrease from a year earlier, with the FY2025 full-year figure at $650000.0, changed N/A from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $783000.0, up from $650000.0 in the prior quarter.
- Over the last five years, Goodwill & Intangibles for MXCT reached as high as $4.6 million in Q1 2025 and fell as low as $650000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn |
| 10 | Maxcyte | 111.68 Mn | 111.68 Mn | 8.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 783,000.00 |
| Dec 31, 2025 | 650,000.00 |
| Sep 30, 2025 | 4.22 Mn |
| Jun 30, 2025 | 4.39 Mn |
| Mar 31, 2025 | 4.57 Mn |